Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep | 40 | 2025 | 458 | 5.330 |
Why?
|
| Sleep Deprivation | 22 | 2023 | 133 | 3.860 |
Why?
|
| Circadian Rhythm | 22 | 2024 | 300 | 3.550 |
Why?
|
| Sleep Apnea, Obstructive | 19 | 2021 | 220 | 3.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 20 | 2024 | 1230 | 2.870 |
Why?
|
| Blood Glucose | 22 | 2021 | 873 | 2.750 |
Why?
|
| Obesity | 22 | 2020 | 1030 | 2.490 |
Why?
|
| Sleep Wake Disorders | 15 | 2023 | 128 | 2.200 |
Why?
|
| Insulin Resistance | 12 | 2018 | 380 | 1.640 |
Why?
|
| Continuous Positive Airway Pressure | 3 | 2016 | 56 | 1.040 |
Why?
|
| Chronobiology Disorders | 2 | 2016 | 4 | 0.930 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2019 | 53 | 0.910 |
Why?
|
| Sleep, REM | 8 | 2014 | 51 | 0.910 |
Why?
|
| Hydrocortisone | 14 | 2024 | 300 | 0.890 |
Why?
|
| Human Growth Hormone | 7 | 2016 | 55 | 0.800 |
Why?
|
| Melatonin | 6 | 2024 | 48 | 0.800 |
Why?
|
| Glycerides | 2 | 2020 | 13 | 0.760 |
Why?
|
| Arachidonic Acids | 2 | 2020 | 38 | 0.760 |
Why?
|
| Endocannabinoids | 2 | 2020 | 27 | 0.750 |
Why?
|
| Diabetes, Gestational | 2 | 2013 | 49 | 0.720 |
Why?
|
| Polysomnography | 17 | 2017 | 155 | 0.700 |
Why?
|
| Circadian Clocks | 3 | 2021 | 66 | 0.660 |
Why?
|
| Insulin | 9 | 2017 | 1190 | 0.640 |
Why?
|
| Humans | 83 | 2025 | 96108 | 0.590 |
Why?
|
| Wakefulness | 6 | 2016 | 138 | 0.580 |
Why?
|
| Diabetes Mellitus | 6 | 2015 | 771 | 0.570 |
Why?
|
| Adult | 46 | 2025 | 28722 | 0.570 |
Why?
|
| Male | 54 | 2025 | 45865 | 0.550 |
Why?
|
| Blood Pressure | 6 | 2021 | 926 | 0.490 |
Why?
|
| Risk Factors | 19 | 2021 | 5961 | 0.490 |
Why?
|
| Neurosecretory Systems | 3 | 2008 | 37 | 0.470 |
Why?
|
| Female | 44 | 2025 | 50030 | 0.460 |
Why?
|
| Prediabetic State | 4 | 2021 | 42 | 0.450 |
Why?
|
| Appetite | 4 | 2009 | 26 | 0.440 |
Why?
|
| Disease Outbreaks | 2 | 2008 | 157 | 0.440 |
Why?
|
| Glucocorticoids | 1 | 2017 | 369 | 0.430 |
Why?
|
| Time Factors | 16 | 2019 | 5580 | 0.430 |
Why?
|
| Leptin | 3 | 2020 | 102 | 0.420 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2011 | 208 | 0.420 |
Why?
|
| Health Status | 4 | 2005 | 386 | 0.410 |
Why?
|
| Glucose Tolerance Test | 9 | 2019 | 235 | 0.410 |
Why?
|
| Middle Aged | 32 | 2025 | 28369 | 0.410 |
Why?
|
| Glucose Intolerance | 2 | 2011 | 101 | 0.400 |
Why?
|
| Occupational Diseases | 1 | 2014 | 57 | 0.400 |
Why?
|
| Aging | 4 | 2005 | 766 | 0.400 |
Why?
|
| Hormones | 2 | 2009 | 144 | 0.350 |
Why?
|
| Sleep Stages | 3 | 2010 | 47 | 0.350 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 142 | 0.340 |
Why?
|
| Metabolism | 1 | 2010 | 27 | 0.330 |
Why?
|
| Autonomic Nervous System | 3 | 2016 | 68 | 0.330 |
Why?
|
| Heart Rate | 3 | 2025 | 518 | 0.330 |
Why?
|
| Aged | 23 | 2025 | 20968 | 0.330 |
Why?
|
| Young Adult | 14 | 2023 | 7026 | 0.330 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 356 | 0.330 |
Why?
|
| Affect | 2 | 2015 | 397 | 0.320 |
Why?
|
| Testosterone | 1 | 2011 | 277 | 0.310 |
Why?
|
| Pregnancy Outcome | 1 | 2011 | 273 | 0.310 |
Why?
|
| Inpatients | 2 | 2016 | 347 | 0.310 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 777 | 0.300 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 424 | 0.300 |
Why?
|
| Brain | 3 | 2017 | 2482 | 0.290 |
Why?
|
| Glucose | 6 | 2021 | 701 | 0.280 |
Why?
|
| Growth Hormone | 3 | 2005 | 99 | 0.280 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1957 | 0.260 |
Why?
|
| Cross-Sectional Studies | 9 | 2024 | 1877 | 0.260 |
Why?
|
| Hunger | 2 | 2016 | 22 | 0.250 |
Why?
|
| Dietary Carbohydrates | 2 | 2010 | 39 | 0.250 |
Why?
|
| Delta Rhythm | 1 | 2005 | 19 | 0.240 |
Why?
|
| Pituitary-Adrenal System | 3 | 2017 | 64 | 0.240 |
Why?
|
| Critical Illness | 3 | 2023 | 346 | 0.230 |
Why?
|
| Epinephrine | 1 | 2005 | 92 | 0.230 |
Why?
|
| Respiratory Rate | 1 | 2025 | 25 | 0.220 |
Why?
|
| Fasting | 5 | 2016 | 164 | 0.220 |
Why?
|
| Bradycardia | 1 | 2025 | 45 | 0.220 |
Why?
|
| Peptide Hormones | 1 | 2004 | 30 | 0.220 |
Why?
|
| Surveys and Questionnaires | 6 | 2019 | 2860 | 0.220 |
Why?
|
| Cardiography, Impedance | 1 | 2004 | 4 | 0.210 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2017 | 258 | 0.200 |
Why?
|
| Vaccination | 2 | 2023 | 311 | 0.200 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2015 | 11 | 0.200 |
Why?
|
| Retinal Ganglion Cells | 1 | 2024 | 74 | 0.200 |
Why?
|
| Diabetic Retinopathy | 1 | 2024 | 82 | 0.200 |
Why?
|
| Body Mass Index | 5 | 2017 | 815 | 0.200 |
Why?
|
| Congresses as Topic | 2 | 2021 | 125 | 0.190 |
Why?
|
| Electroencephalography | 5 | 2017 | 824 | 0.190 |
Why?
|
| Adolescent | 11 | 2023 | 9896 | 0.190 |
Why?
|
| Cross-Over Studies | 6 | 2017 | 397 | 0.180 |
Why?
|
| Vaccines | 1 | 2023 | 84 | 0.180 |
Why?
|
| Meals | 1 | 2021 | 22 | 0.170 |
Why?
|
| Research Report | 1 | 2021 | 43 | 0.170 |
Why?
|
| Influenza Vaccines | 1 | 2002 | 173 | 0.170 |
Why?
|
| Aged, 80 and over | 6 | 2023 | 7229 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2002 | 348 | 0.160 |
Why?
|
| Energy Metabolism | 3 | 2015 | 312 | 0.160 |
Why?
|
| Hospitalization | 2 | 2016 | 943 | 0.160 |
Why?
|
| Fatigue | 2 | 2011 | 185 | 0.150 |
Why?
|
| Exercise | 1 | 2003 | 354 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 2 | 2017 | 281 | 0.150 |
Why?
|
| Prevalence | 4 | 2014 | 1349 | 0.150 |
Why?
|
| Prospective Studies | 7 | 2017 | 4671 | 0.150 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 106 | 0.150 |
Why?
|
| Phototherapy | 1 | 2018 | 36 | 0.140 |
Why?
|
| Attention | 1 | 2003 | 413 | 0.140 |
Why?
|
| Social Class | 1 | 1999 | 145 | 0.140 |
Why?
|
| Ghrelin | 2 | 2010 | 29 | 0.140 |
Why?
|
| Jet Lag Syndrome | 4 | 2019 | 13 | 0.140 |
Why?
|
| Thyroid Gland | 1 | 2019 | 281 | 0.140 |
Why?
|
| Hyperglycemia | 2 | 2016 | 181 | 0.130 |
Why?
|
| Habits | 1 | 2017 | 17 | 0.130 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2017 | 44 | 0.130 |
Why?
|
| Poverty | 1 | 1999 | 196 | 0.130 |
Why?
|
| Animals | 9 | 2021 | 28891 | 0.130 |
Why?
|
| Carbohydrate Metabolism | 2 | 2008 | 32 | 0.130 |
Why?
|
| Time | 1 | 2016 | 79 | 0.120 |
Why?
|
| Treatment Outcome | 4 | 2017 | 9175 | 0.120 |
Why?
|
| Norepinephrine | 1 | 2016 | 174 | 0.120 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2016 | 36 | 0.120 |
Why?
|
| Hyperphagia | 1 | 2016 | 35 | 0.120 |
Why?
|
| Pregnancy | 2 | 2013 | 3240 | 0.110 |
Why?
|
| Hormone Replacement Therapy | 2 | 2013 | 97 | 0.110 |
Why?
|
| Comorbidity | 3 | 2015 | 1011 | 0.110 |
Why?
|
| Hypertension | 3 | 2014 | 774 | 0.110 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2008 | 81 | 0.110 |
Why?
|
| Lighting | 2 | 2012 | 34 | 0.110 |
Why?
|
| Sex Factors | 4 | 2010 | 1133 | 0.100 |
Why?
|
| Actigraphy | 4 | 2017 | 61 | 0.100 |
Why?
|
| Snoring | 2 | 2017 | 12 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2015 | 244 | 0.100 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2013 | 71 | 0.100 |
Why?
|
| Hypopituitarism | 1 | 2013 | 19 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 432 | 0.100 |
Why?
|
| Motor Activity | 1 | 2015 | 332 | 0.100 |
Why?
|
| Energy Intake | 1 | 2013 | 100 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 206 | 0.100 |
Why?
|
| Brain Waves | 1 | 2013 | 36 | 0.100 |
Why?
|
| Biomarkers | 2 | 2023 | 1931 | 0.100 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 66 | 0.090 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2017 | 132 | 0.090 |
Why?
|
| Logistic Models | 2 | 2016 | 1268 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2015 | 221 | 0.090 |
Why?
|
| Kidney | 1 | 2017 | 1137 | 0.090 |
Why?
|
| Cohort Studies | 5 | 2019 | 3110 | 0.090 |
Why?
|
| Healthy Volunteers | 3 | 2017 | 157 | 0.090 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 71 | 0.090 |
Why?
|
| Adipocytes | 1 | 2012 | 170 | 0.090 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 69 | 0.090 |
Why?
|
| Child | 3 | 2019 | 7626 | 0.080 |
Why?
|
| Age Factors | 4 | 2010 | 1963 | 0.080 |
Why?
|
| Thyrotropin | 3 | 2010 | 311 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2007 | 983 | 0.080 |
Why?
|
| Random Allocation | 2 | 2017 | 325 | 0.080 |
Why?
|
| Postprandial Period | 2 | 2010 | 48 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2012 | 522 | 0.080 |
Why?
|
| Prolactin | 2 | 2005 | 89 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 615 | 0.070 |
Why?
|
| Quality of Life | 2 | 2010 | 1816 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2012 | 460 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2010 | 252 | 0.070 |
Why?
|
| Vagus Nerve | 2 | 2005 | 50 | 0.070 |
Why?
|
| Metabolic Syndrome | 2 | 2015 | 123 | 0.070 |
Why?
|
| Inflammation | 1 | 2014 | 1063 | 0.070 |
Why?
|
| Weight Gain | 1 | 2008 | 129 | 0.070 |
Why?
|
| Sympathetic Nervous System | 2 | 2005 | 99 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2023 | 10287 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2016 | 908 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1981 | 0.060 |
Why?
|
| Acetamides | 1 | 2005 | 27 | 0.060 |
Why?
|
| Alpha Rhythm | 1 | 2005 | 27 | 0.060 |
Why?
|
| Body Temperature | 1 | 2005 | 131 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2006 | 599 | 0.060 |
Why?
|
| Respiratory Mechanics | 1 | 2005 | 114 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2007 | 338 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 935 | 0.050 |
Why?
|
| Homeostasis | 3 | 2015 | 467 | 0.050 |
Why?
|
| Pituitary Gland | 1 | 2004 | 118 | 0.050 |
Why?
|
| Hypoxia | 1 | 2008 | 681 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2023 | 181 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 312 | 0.050 |
Why?
|
| Somatoform Disorders | 1 | 2002 | 31 | 0.050 |
Why?
|
| Loneliness | 1 | 2002 | 27 | 0.050 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 1981 | 2 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2008 | 2480 | 0.040 |
Why?
|
| Heart | 1 | 2004 | 591 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 481 | 0.040 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2000 | 7 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 640 | 0.040 |
Why?
|
| Seasons | 1 | 1981 | 246 | 0.040 |
Why?
|
| Geriatric Assessment | 2 | 2015 | 192 | 0.040 |
Why?
|
| Overweight | 1 | 2019 | 121 | 0.030 |
Why?
|
| Incidence | 2 | 2014 | 1715 | 0.030 |
Why?
|
| Area Under Curve | 2 | 2010 | 340 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 328 | 0.030 |
Why?
|
| Adiposity | 1 | 2017 | 76 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 250 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 2882 | 0.030 |
Why?
|
| Appetite Regulation | 1 | 2016 | 7 | 0.030 |
Why?
|
| Food Deprivation | 1 | 2015 | 23 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2015 | 19 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 982 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 938 | 0.030 |
Why?
|
| Eating | 1 | 2016 | 165 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 901 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1010 | 0.030 |
Why?
|
| Accelerometry | 1 | 2015 | 48 | 0.030 |
Why?
|
| Wisconsin | 1 | 2014 | 46 | 0.030 |
Why?
|
| Arousal | 2 | 2008 | 173 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 344 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 189 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2015 | 93 | 0.030 |
Why?
|
| C-Peptide | 1 | 1994 | 186 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 404 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2017 | 347 | 0.030 |
Why?
|
| Rats | 1 | 2000 | 4155 | 0.030 |
Why?
|
| Reward | 1 | 2016 | 209 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 1562 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 162 | 0.020 |
Why?
|
| Kinetics | 1 | 1994 | 1562 | 0.020 |
Why?
|
| Length of Stay | 1 | 2015 | 833 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 367 | 0.020 |
Why?
|
| Acylation | 1 | 2010 | 68 | 0.020 |
Why?
|
| Chicago | 1 | 2015 | 1506 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2015 | 441 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2010 | 147 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2010 | 169 | 0.020 |
Why?
|
| Employment | 1 | 2010 | 57 | 0.020 |
Why?
|
| Health Surveys | 1 | 2010 | 245 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 674 | 0.020 |
Why?
|
| Life Style | 1 | 2010 | 186 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1973 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 713 | 0.020 |
Why?
|
| Glucaric Acid | 1 | 2005 | 5 | 0.010 |
Why?
|
| Neoplasms | 1 | 2021 | 3248 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2005 | 63 | 0.010 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2005 | 106 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 273 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 3581 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 12537 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2005 | 1791 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1981 | 150 | 0.010 |
Why?
|
| Health Behavior | 1 | 2002 | 191 | 0.010 |
Why?
|
| Students | 1 | 2002 | 179 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 340 | 0.010 |
Why?
|
| United States | 1 | 2010 | 7768 | 0.010 |
Why?
|